Cantel Medical Corp. trades as part of the medical instruments and equipment industry and trades as part of the healthcare sector. The company CEO is George L. Fotiades. Cantel Medical Corp is dedicated in delivering infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.
Previous Intraday Trading Performance:
The CMD stock showed a previous change of -0.51% with an open at 68.51 and a close of 67.90. It reached an intraday high of 68.87 and a low of 67.72.
The stock has a market cap of $2.8b with 41.7m shares outstanding, of which the float is 36.6m shares. Trading volume reached 294,686 shares compared to its average volume of 309,177 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.
Historical Trading Performance:
Over the last five trading days, Cantel Medical Corp. shares returned -0.69% and in the past 30 trading days it returned -0.85%. Over three months, it changed -13.95%. In one year it has changed -40.00% and within that year its 52-week high was 130.92 and its 52-week low was 63.68. CMD stock is 6.63% above its 52 Week Low.
Our calculations show a 200 day moving average of 83.91 and a 50 day moving average of 73.11. Currently CMD stock is trading -19.08% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.
The last annual fiscal EPS for the company was reported at 2.19 that ended on 31st of July 2018, which according to the previous close, that is a PE of 31.00. Based on 1 analyst estimate, the estimated EPS for the next quarter is 0.60. The TTM EPS is 2.43, which comes to a TTM PE of 27.94. Historically, the PE high was 76.60 and the PE low was 27.10. If the stock reached its PE low, that would represent a price of 65.86, which is a decrease of -3.01%.
The dividend per share is currently 0.20, which is a dividend yield of 0.29%. Also, the payout ratio is 8.23%, therefore the dividend is safe according to our calculations.
Base on our calculations, the intrinsic value per share is 82.58, which means it is possibly undervalued and has a margin of safety of 17.78%
Indicators to Watch:
Based on the latest filings, there is 12.20% of insider ownership and 126.30% of institutional ownership. Short-interest is 1,483,527, which is 3.56% of shares outstanding. The short-interest ratio or days-to-cover ratio is 3.58. This stock has some short interest, but it may be normal and no cause for concern if long the position.
The current calculated beta is 1.11
Based on last reported financials, the company’s return on equity is 11.97%, return on assets is 7.72%, profit margin is 8.22%, price-to-sales is 3.18 and price-to-book is 4.44.
All scores are out of six:
2 :Valuation Score
2 :Past Performance Score
5 :Financial Strength Score
3 :Future Growth Score
0 :Dividend Score
3 :Overall Score